Cloned cDNA of A/swine/Iowa/15/1930 internal genes as a candidate backbone for reverse genetics vaccine against influenza A viruses.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Vaccine

• Publication date

  2012-02-14

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.vaccine.2011.12.109PMID 22230579PMCID PMC3274597
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Highly pathogenic avian influenza virus H5N1 from Egypt escapes vaccine-induced immunity but confers clinical protection against a heterologous clade 2.2.1 Egyptian isolate.

  2011cited by this paper
• Adaptation of a Madin-Darby canine kidney cell line to suspension growth in serum-free media and comparison of its ability to produce avian influenza virus to Vero and BHK21 cell lines.

  2011cited by this paper
• Protective efficacy of H5 inactivated vaccines in meat turkey poults after challenge with Egyptian variant highly pathogenic avian influenza H5N1 virus.

  2011cited by this paper
• Implications of global and regional patterns of highly pathogenic avian influenza virus H5N1 clades for risk management.

  2011cited by this paper
• Efficacy of Avian Influenza Vaccine in Poultry: A Meta-analysis

  2010cited by this paper
• Viral reassortment and transmission after co-infection of pigs with classical H1N1 and triple-reassortant H3N2 swine influenza viruses

  2010cited by this paper
• Antigenic and genetic characteristics of influenza A(H5N1) and influenza A(H9N2) viruses and candidate vaccine viruses developed for potential use in human vaccines - February 2010.

  2010cited by this paper
• First whole genome characterization of swine influenza virus subtype H3N2 in Thailand.

  2010cited by this paper
• Molecular evolution of H5N1 in Thailand between 2004 and 2008.

  2009cited by this paper
• Molecular epidemiology of H5N1 avian influenza.

  2009cited by this paper
• Occurrence of swine influenza virus infection in swine with porcine respiratory disease complex.

  2008cited by this paper
• Planning and executing a vaccination campaign against avian influenza.

  2007cited by this paper
• Genome Analysis Linking Recent European and African Influenza (H5N1) Viruses

  2007cited by this paper
• Novel Swine Influenza Virus Subtype H3N1, United States

  2006cited by this paper
• The development and characterization of H5 influenza virus vaccines derived from a 2003 human isolate.

  2006cited by this paper
• H5N1 Outbreaks and Enzootic Influenza

  2006cited by this paper
• Emergence and predominance of an H5N1 influenza variant in China

  2006cited by this paper
• The immunogenicity and efficacy against H5N1 challenge of reverse genetics-derived H5N3 influenza vaccine in ducks and chickens.

  2006cited by this paper
• Establishment of multiple sublineages of H5N1 influenza virus in Asia: implications for pandemic control.

  2006cited by this paper
• Protective efficacy in chickens, geese and ducks of an H5N1-inactivated vaccine developed by reverse genetics.

  2005cited by this paper
• Avian flu: H5N1 virus outbreak in migratory waterfowl

  2005cited by this paper
• Characterization of the Reconstructed 1918 Spanish Influenza Pandemic Virus

  2005cited by this paper
• Generation of reassortant influenza vaccines by reverse genetics that allows utilization of a DIVA (Differentiating Infected from Vaccinated Animals) strategy for the control of avian influenza.

  2004cited by this paper
• Genesis of a highly pathogenic and potentially pandemic H5N1 influenza virus in eastern Asia

  2004cited by this paper
• Vaccination of chickens against H5N1 avian influenza in the face of an outbreak interrupts virus transmission

  2004cited by this paper
• Generation of High-Yielding Influenza A Viruses in African Green Monkey Kidney (Vero) Cells by Reverse Genetics

  2004cited by this paper
• Preparation of a standardized, efficacious agricultural H5N3 vaccine by reverse genetics.

  2003cited by this paper
• An Update on Avian Influenza in Hong Kong 2002

  2003cited by this paper
• Protection of chickens against highly lethal H5N1 and H7N1 avian influenza viruses with a recombinant fowlpox virus co-expressing H5 haemagglutinin and N1 neuraminidase genes

  2003cited by this paper
• The annual production cycle for influenza vaccine.

  2003cited by this paper
• Evaluation of a genetically modified reassortant H5N1 influenza A virus vaccine candidate generated by plasmid-based reverse genetics.

  2003cited by this paper
• Eight-plasmid system for rapid generation of influenza virus vaccines.

  2002cited by this paper
• Universal primer set for the full-length amplification of all influenza A viruses

  2001cited by this paper
• Vaccines protect chickens against H5 highly pathogenic avian influenza in the face of genetic changes in field viruses over multiple years.

  2000cited by this paper
• Development of a mammalian cell (Vero) derived candidate influenza virus vaccine.

  1998cited by this paper
• A pandemic warning?

  1997cited by this paper
• Evolution and ecology of influenza A viruses

  1992cited by this paper
• Evolution and ecology of influenza A viruses.

  1992cited by this paper
• Relative efficacy of embryonated eggs and cell culture for isolation of contemporary influenza viruses

  1981cited by this paper
• A SIMPLE METHOD OF ESTIMATING FIFTY PER CENT ENDPOINTS

  1938cited by this paper
• NEUTRALIZATION TESTS WITH SERA OF CONVALESCENT OR IMMUNIZED ANIMALS AND THE VIRUSES OF SWINE AND HUMAN INFLUENZA

  1936cited by this paper
• THE INCIDENCE OF NEUTRALIZING ANTIBODIES FOR SWINE INFLUENZA VIRUS IN THE SERA OF HUMAN BEINGS OF DIFFERENT AGES

  1936cited by this paper
• SWINE INFLUENZA

  1934cited by this paper
• SWINE INFLUENZA

  1931cited by this paper

• Dual effects of ipecac alkaloids with potent antiviral activity against foot-and-mouth disease virus as replicase inhibitors and direct virucides

  2024cites this paper
• Naturally Derived Terpenoids Targeting the 3Dpol of Foot-and-Mouth Disease Virus: An Integrated In Silico and In Vitro Investigation

  2024influential citation
• The Application of the Gibson Assembly Method in the Production of Two pKLS3 Vector-Derived Infectious Clones of Foot-and-Mouth Disease Virus

  2023cites this paper
• Antiviral mechanisms of sorafenib against foot-and-mouth disease virus via c-RAF and AKT/PI3K pathways

  2023cites this paper
• Small Molecules Targeting 3C Protease Inhibit FMDV Replication and Exhibit Virucidal Effect in Cell-Based Assays

  2023cites this paper
• Rapid Spread and Genetic Characterisation of a Recently Emerged Recombinant Lumpy Skin Disease Virus in Thailand

  2022cites this paper
• Non-Nucleoside Inhibitors Decrease Foot-and-Mouth Disease Virus Replication by Blocking the Viral 3Dpol

  2022cites this paper
• Andrographolide and Deoxyandrographolide Inhibit Protease and IFN-Antagonist Activities of Foot-and-Mouth Disease Virus 3Cpro

  2022cites this paper
• Natural Phytochemicals, Luteolin and Isoginkgetin, Inhibit 3C Protease and Infection of FMDV, In Silico and In Vitro

  2021cites this paper
• A Novel Plasmid DNA-Based Foot and Mouth Disease Virus Minigenome for Intracytoplasmic mRNA Production

  2021cites this paper
• Genetic Engineering Technique in Virus-Like Particle Vaccine Construction

  2021cites this paper
• Structural-based virtual screening and in vitro assays for small molecules inhibiting the feline coronavirus 3CL protease as a surrogate platform for coronaviruses

  2020cites this paper
• In silico and in vitro analysis of small molecules and natural compounds targeting the 3CL protease of feline infectious peritonitis virus

  2019cites this paper
• Perceptions of vaccination within a Christian homeschooling community in Pennsylvania.

  2019cites this paper
• Immunogenicity of transmembrane deleted-G protein of bovine ephemeral fever virus (BEFV) expressed in insect cells

  2018cites this paper
• Avian influenza outbreaks in Malaysia, 1980 – 2017

  2017cites this paper
• G45R on nonstructural protein 1 of influenza A virus contributes to virulence by increasing the expression of proinflammatory cytokines in mice

  2016cites this paper
• G45R mutation in the nonstructural protein 1 of A/Puerto Rico/8/1934 (H1N1) enhances viral replication independent of dsRNA-binding activity and type I interferon biology

  2016cites this paper
• NS gene of influenza virus A/swine/IA/15/30 increases the replication rate of A/Puerto Rico/8/34 in MDCK and Vero cells

  2015cites this paper
• Screening for lead compounds and herbal extracts with potential anti-influenza viral activity.

  2014cites this paper
• Vaccines based on structure-based design provide protection against infectious diseases

  2013cites this paper